Live
- Wangchuk continues indefinite hunger strike
- Oh! Musi relocatees left parched by water woes
- Ongole: Regular health check-ups for students recommended
- All options weighed to turnaround VSP: CM Naidu
- SI & 6 cops suspended for tracing SP’s location
- Naidu makes Centre understand damage done by YSRCP govt
- 50 Sr docs of RG Kar Hospital quits in support juniors’ protest
- Why entrepreneurship training is essential for students
- Career fair connects students globally
- Watch The Viral Video Of Durga Puja Celebrated For The First Time At Times Square, New York
iGenetic develops RT-PCR kits for Covid-19 testing
Mumbai-based specialty diagnostic major iGenetic Diagnostics and Thane-based Biogenomics jointly developed RT-PCR testing kits with 100 per cent concordance to true positives and true negatives and have received approval from Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
Hyderabad: Mumbai-based specialty diagnostic major iGenetic Diagnostics and Thane-based Biogenomics jointly developed RT-PCR testing kits with 100 per cent concordance to true positives and true negatives and have received approval from Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
The RT-PCR kit, considered to be the gold standard for diagnosis of Covid-19, has jointly been developed by iGenetic & Biogenomics and Biogenomics is working on manufacturing and distribution across the country. The kits are expected to be available in the market within a few weeks. The availability of the kits will boost testing capabilities in the Hyderabad which has nearly 2,891 confirmed cases of coronavirus that has claimed 92 lives.
"India has already began testing one lakh people a day and our kits will offer a boost to the efforts of ramping up the testing capability further. The RT-PCR test kits have been approved after satisfying the stringent guidelines of ICMR and NIV that squeeze the chances of a false positive or a false negative to zero. These kits are better than global kits in terms of quality, adaptability, and price," said Arunima Patel, founder & CEO, iGenetic Diagnostics.
